Bio-Techne Corporation (TECH)

G1 Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	73.4	168.11	285.26	272.05	140.41
Depreciation & Amortization	109.9	65.11	62.94	60.47	51.25
Other Amortization	-	46.6	44.3	40.6	36.5
Loss (Gain) From Sale of Assets	80.5	21.96	-11.68	-	-
Asset Writedown & Restructuring Costs	21.31	2.63	-	19.26	-
Loss (Gain) From Sale of Investments	-	-0.28	-37.65	-15	67.88
Loss (Gain) on Equity Investments	-0.94	6.84	1.14	-	-
Stock-Based Compensation	40.83	38.04	39.23	42.18	48.98
Other Operating Activities	-37.46	-39.93	-38.57	-24.77	-22.12
Change in Accounts Receivable	-	-20.53	-20.87	-57.6	-15.55
Change in Inventory	-	-14.22	-30.17	-32.01	-7.14
Change in Accounts Payable	-	25.77	-7.91	12.74	19.09
Change in Income Taxes	-	-10.6	-2.49	2.67	13.43
Change in Other Net Operating Assets	-	9.47	-29.14	4.68	19.44
Operating Cash Flow	287.56	298.98	254.39	325.27	352.16
Operating Cash Flow Growth	-3.82%	17.53%	-21.79%	-7.64%	71.61%
Capital Expenditures	-31.01	-62.88	-38.24	-44.91	-44.3
Sale of Property, Plant & Equipment	2.45	-	-	-	-
Cash Acquisitions	-	-169.71	-101.18	-	-225.35
Divestitures	-	-	17.82	-	-
Investment in Securities	-6.62	29.55	-144.05	-26.94	26.14
Other Investing Activities	-	-	-	-25	-
Investing Cash Flow	-35.18	-203.03	-265.65	-96.85	-243.52
Long-Term Debt Issued	27	225	619.66	90	256
Long-Term Debt Repaid	-	-256	-525.66	-175.5	-271.5
Net Debt Issued (Repaid)	27	-31	94	-85.5	-15.5
Issuance of Common Stock	51.74	60.94	29.81	77.16	65.09
Repurchase of Common Stock	-282.25	-101.91	-48.46	-184.41	-62.52
Common Dividends Paid	-50.39	-50.42	-50.29	-50.19	-49.62
Other Financing Activities	-	-	-2.46	0.09	-
Financing Cash Flow	-253.91	-122.4	22.62	-242.85	-62.55
Foreign Exchange Rate Adjustments	11.93	-2.33	-3.36	-12.09	6.37
Net Cash Flow	10.4	-28.78	8	-26.52	52.47
Free Cash Flow	256.55	236.1	216.15	280.36	307.86
Free Cash Flow Growth	8.66%	9.23%	-22.90%	-8.93%	100.60%
Free Cash Flow Margin	21.04%	20.37%	19.02%	25.36%	33.07%
Free Cash Flow Per Share	1.61	1.47	1.33	1.71	1.90
Cash Interest Paid	-	14.5	8.37	11.03	13.58
Cash Income Tax Paid	-	65.25	88.43	30.34	20.95
Levered Free Cash Flow	230.4	214.4	186.5	214.22	257.4
Unlevered Free Cash Flow	230.4	224.24	193.51	221.29	266.12
Change in Working Capital	-	-10.11	-90.58	-69.52	29.26

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q